#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Wolfram syndrome Transplant rejection Synovitis Antiphospholipid antibodies Hypophosphatasia Paraneoplastic neurological syndrome Myxofibrosarcoma Stevens-Johnson syndrome Follicular lymphoma stage III Rhabdomyosarcoma recurrent Henoch-Schonlein purpura nephritis Staphylococcal infection Extra-osseous Ewing's sarcoma recurrent KBG syndrome Chronic graft versus host disease More trials…

    Learn about Rare Diseases

    Carcinoid syndrome – Basic Information Pulmonary fibrosis – Life with Disease Immunodeficiency congenital – Treatment Glycogen storage disease type I – Treatment Chondrosarcoma metastatic – Diagnostics Angiosarcoma metastatic – Treatment Haemophilia A without inhibitors Rett syndrome – Diagnostics Factor IX deficiency Paroxysmal nocturnal haemoglobinuria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Colecalciferol Triptorelin Pamoate Tacrolimus Dopamine Hydrochloride Contezolid Cholic Acid LUTETIUM LU-177 Vibozilimod Efmoroctocog Alfa Isosorbide Dinitrate Panitumumab Ozanimod Asciminib Propranolol Hydrochloride Elasomeran Azd9550 Tuvusertib Quemliclustat Brexpiprazole Belzutifan More therapies…

    Learn about Your Condition

    Growth hormone deficiency Tooth loss Adenocarcinoma Craniocerebral injury Hodgkin's disease Breast cancer stage III Drug eruption Bipolar disorder Acute HIV infection Renal transplant Vascular graft thrombosis Alcoholism Albright's disease Non-obstructive cardiomyopathy Measles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study of CRN09682 for Patients with Neuroendocrine Tumors and Other Solid Tumors that Express Somatostatin Receptor Type 2

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Neoplasm
    France Germany Italy Spain

  • A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

    Recruiting

    2 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    France Germany Italy Poland Spain

  • A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • ZUNIBERGENE ROCPARVOVEC
    • Aflibercept
    Bulgaria France Germany Hungary Italy Latvia +3

  • Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Heparin
    • Human Plasma Protein
    France

  • Study of ALE.

    Recruiting

    2 1 1
    Investigated Drugs:
    • ALE.P03
    France Italy The Netherlands Spain

  • A Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Spain
Previous Page
1 … 97 98 99 100 101 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!